Insider · CIK 0002058197
Maricel Apuli
officer
Files at BBIO (BridgeBio Pharma, Inc.). First filing May 6, 2025, latest Dec 10, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $233k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BBIO: BridgeBio Pharma, Inc.
BBIOOct 9, 2026 · close 65.35
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 14Weak | BridgeBio Pharma, Inc. | $149k 2,000 shares | -2% | +186% from low-1% from high | |
| 36Weak | BridgeBio Pharma, Inc. | $45k 1,000 shares | -1% | +106% from low-7% from high | |
| 36Weak | BridgeBio Pharma, Inc. | $40k 1,026 shares | -1% | +73% from low0% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock | -2,003 | $75.15 | $151k | 128,294 | Dec 16, 2025 |
| Dec 8, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -2,000 | $74.26 | $149k | 130,297 | Dec 10, 2025 |
| Nov 16, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock | -4,781 | $66.39 | $317k | 132,297 | Nov 18, 2025 |
| Aug 16, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock | -4,781 | $51.32 | $245k | 137,078 | Aug 19, 2025 |
| Aug 7, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock | -1,000 | $45.44 | $45k | 141,859 | Aug 11, 2025 |
| May 16, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock | -4,780 | $33.84 | $162k | 142,859 | May 20, 2025 |
| May 2, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock | -1,026 | $38.51 | $40k | 147,639 | May 6, 2025 |
| Mar 19, 2025 | BBIO BridgeBio Pharma, Inc. | AGrant or award Common Stock | +23,660 | $0.00 | $0 | 148,665 | Mar 21, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.